COPD is associated with reduced pulmonary interstitial expression of pentraxin-3
Open Access
- 15 September 2011
- journal article
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 39 (4), 830-838
- https://doi.org/10.1183/09031936.00138110
Abstract
Pentraxin (PTX)3 is involved in antimicrobial defence, apoptotic cell clearance and extracellular matrix stability. As these processes are altered in chronic obstructive pulmonary disease (COPD), we aimed to investigate PTX3 expression in patients with this disease. PTX3 expression was quantified by immunohistochemical staining of lung tissue from never-smokers, smokers without COPD, and in patients with COPD of Global Initiative for Chronic Obstructive Lung Disease (GOLD) stage I, II and III–IV. mRNA expression was examined in total lung tissue by quantitative RT-PCR. PTX3 concentration was measured in induced sputum and plasma by ELISA. PTX3 is mainly localised in the interstitium of the small airways and alveolar walls. There were no significant differences in pulmonary, sputum and plasma PTX3 expression between study groups. However, PTX3 expression in small airways correlated significantly with forced expiratory volume in 1 s (r=0.35, p=0.004). In the alveolar walls, PTX3 expression correlated significantly with carbon monoxide transfer coefficient (r=0.28, p=0.04). In sputum, PTX3 levels were highly correlated with the number of neutrophils. Finally, systemic levels of PTX3 tended to be lower in severe COPD compared with mild COPD. In COPD, airflow limitation and reduced transfer coefficient for carbon monoxide are associated with lower pulmonary interstitial expression of PTX3.Keywords
This publication has 40 references indexed in Scilit:
- Cigarette smoke induces PTX3 expression in pulmonary veins of mice in an IL-1 dependent mannerRespiratory Research, 2010
- Relevance of lower airway bacterial colonization, airway inflammation, and pulmonary function in the stable stage of chronic obstructive pulmonary diseaseEuropean Journal of Clinical Microbiology & Infectious Diseases, 2010
- The Long Pentraxin PTX3: A Modulator of the Immunoinflammatory Response in Atherosclerosis and Cardiovascular DiseasesTrends in Cardiovascular Medicine, 2010
- Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destructionEuropean Respiratory Journal, 2008
- The Immunopathogenesis of Chronic Obstructive Pulmonary Disease: Insights from Recent ResearchProceedings of the American Thoracic Society, 2007
- The humoral pattern recognition receptor PTX3 is stored in neutrophil granules and localizes in extracellular trapsThe Journal of Experimental Medicine, 2007
- Elevated MMP-12 protein levels in induced sputum from patients with COPDThorax, 2006
- Cytokine-induced gene expression at the crossroads of innate immunity, inflammation and fertility: TSG-6 and PTX3/TSG-14Cytokine & Growth Factor Reviews, 2004
- The Nature of Small-Airway Obstruction in Chronic Obstructive Pulmonary DiseaseNew England Journal of Medicine, 2004
- Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune responseNature, 2002